A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding ...

High-intensity electrical pulses have been medically used to destroy tumors while sparing healthy tissue. But lower-intensity ...

The global humanized mouse model market is poised for substantial growth, with projections indicating a rise from USD 101.5 million in 2023 to USD 178.3 million by 2033, growing at a steady CAGR of ...

Researchers identified a direct connection between cancer-related inflammation and the loss of motivation characteristic of advanced cancer. In a mouse study, they describe a brain pathway that starts ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

In a major step forward for cancer treatment, researchers have developed a new type of “smart” chemical that attacks ...

The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the unavoidable consequences of their declining physical health and extreme weight loss.

New research shows that apathy and fatigue in advanced cancer are driven not by physical decline, but by inflammation-sensing neurons that suppress motivation.

City of Hope researchers demonstrate proof of concept for a novel targeted therapy for pancreatic cancer, exploiting transcription-replication conflicts to combat treatment resistance.